🇺🇸 FDA
Pipeline program

PIRTOBRUTINIB, IBRUTINIB, PIRTOBRUTINIB, IBRUTINIB

LOXO-BTK-20019

Phase 3 small_molecule active

Quick answer

PIRTOBRUTINIB, IBRUTINIB, PIRTOBRUTINIB, IBRUTINIB for Mantle cell lymphoma is a Phase 3 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Mantle cell lymphoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials